Squarepoint Ops LLC Sc Pharmaceuticals Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.51 - $5.21 $149,908 - $222,513	-42,709 Reduced 68.59%	19,554 $85,000
Q1 2024 May 15, 2024	BUY	$4.86 - $6.39 $59,335 - $78,015	12,209 Added 24.39%	62,263 $312,000
Q4 2023 Feb 14, 2024	BUY	$4.7 - $6.63 $235,253 - $331,858	50,054 New	50,054 $313,000
Q1 2023 May 15, 2023	BUY	$5.59 - $9.47 $414,805 - $702,721	74,205 New	74,205 $673,000
Q4 2020 Feb 16, 2021	SELL	$5.17 - $9.41 $53,064 - $96,584	-10,264 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$7.12 - $8.86 $183,062 - $227,799	-25,711 Reduced 71.47%	10,264 $76,000
Q2 2020 Aug 14, 2020	BUY	$7.01 - $10.96 $99,352 - $155,336	14,173 Added 65.01%	35,975 $265,000
Q1 2020 May 15, 2020	SELL	$5.4 - $10.45 $177,730 - $343,940	-32,913 Reduced 60.15%	21,802 $161,000
Q4 2019 Feb 14, 2020	BUY	$4.1 - $6.21 $224,331 - $339,780	54,715 New	54,715 $310,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $95.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.